Open Label Phase II Study of BAY 43-9006 in Chronic Myelogenous Leukemia (CML) Patients Resistant to Gleevec

Clinical trial NCT00661180 · COMPLETED

Trial details

NCT number: NCT00661180
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myelogenous Leukemia

Start date: 2004-01-01
Primary completion: 2005-02-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.